Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice

Hepatology

Volumn 48, Issue 3, 2008, Pages 770-781

  Ma, Kun L ^a   Ruan, Xiong Z ^a,b   Powis, Stephen H ^a   Chen, Yaxi ^b   Moorhead, John F ^a   Varghese, Zac ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; BINDING PROTEIN; CASEIN; CHOLESTEROL; CYTOKINE; INTERLEUKIN 1BETA; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL STIMULATION; CELL STRAIN HEPG2; CELL TRANSPORT; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GOLGI COMPLEX; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; LIPID STORAGE; LIVER CELL; LIVER CELL CULTURE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLESTEROL; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FATTY LIVER; HEPATOCYTES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPID METABOLISM; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR ALPHA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, LDL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51349135630     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22423     Document Type: Article

References (18)

1. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998;4:842-845.
2. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;5:1183-1192.
3. Lalor P, Faint J, Aarbodem Y, Hubscher S, Adams D. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007;2:173-193.
4. Hillgartner FB, Salati LM, Goodridge AG. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev 1995;1:47-76.
5. Nohturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, Brown MS. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci U S A 1999; 20:11235-11240.
6. Timmins JM, Lee JY, Boudyguina E, Muckman KD, Brunham LR, Mulya A, et al. Targeted inactivation of hepatic Abcal causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 2005;5:1333-1342.
7. Schmitz G, Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 2005;1:1-19.
8. Francavilla A, Carr BI, Azzarone A, Polimeno L, Wang ZQ, Vanthiel DH, et al. Hepatocyte proliferation and gene-expression induced by triiodothyronine in-vivo and in-vitro. HEPATOLOGY 1994;5:1237-1241.
9. Ruan XZ, Varghese Z, Fernando R, Moorhead JF. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998;6:1391-1397.
10. Ma KL, Ruan XZ, Powis SH, Moorhead JF, Varghese Z. Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2007;6:H2721-H2728.
11. Gamble W, Vaughan M, Kruth HS, Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978;8:1068-1070.
12. Ruan XZ, Varghese Z, Powis SH, Moorhead JF. Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation. Kidney Int 2001;5:1716-1725.
13. Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, et al. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 2006;5:1150-1155.
14. Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM. Relationships between estimates of adiposity, insulin resistance and nonalcoholic fatty liver disease in a large group of nondiabetic korean adults. Diabetes Care 2007;8:2113-2118.
15. Canbay A, Bechmann LP, Best J, Jochum C, Treichel U, Gerken G. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. Z Gastroenterol 2006;3:245-248.
16. Bleibel W, Thukral C, Robson SC. Overlap between systemic lupus erthematosus and nonalcoholic steatohepatisis: Response. J Clin Gastroenterol 2006;6:561-562.
17. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 2007;1:63-70.
18. Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diabetes Rep 2002;3:210-215.